Literature DB >> 12944906

Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53.

Koji Ueda1, Hirofumi Arakawa, Yusuke Nakamura.   

Abstract

Dual-specificity phosphatase 5 (DUSP5), a VH1-like enzyme that hydrolyses nuclear substrates phosphorylated on both tyrosine and serine/threonine residues, has a potential role in deactivation of mitogen- or stress-activated protein kinases. Using cDNA-microarray technology, we found that the expression of DUSP5 mRNA was dramatically increased by exogenous p53 in U373MG, a p53-mutant glioblastoma cell line. Transcription of DUSP5 was also remarkably activated by endogenous p53 in response to DNA damage in colon-cancer cells (p53+/+) that contained wild-type p53, but not in p53-/- cells. Chromatin-immunoprecipitation (ChIP) and reporter assays demonstrated that endogenous p53 protein would bind directly to the promoter region of the DUSP5 gene, implying p53-dependent transcriptional activity. Overexpression of DUSP5 suppressed the growth of several types of human cancer cells, in which Erk1/2 was significantly dephosphorylated. If, as the results suggest, DUSP5 is a direct target of p53, it represents a novel mechanism by which p53 might negatively regulate cell-cycle progression by downregulating mitogen- or stress-activated protein kinases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12944906     DOI: 10.1038/sj.onc.1206845

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  45 in total

1.  Chromatin immunoprecipitation-based screen to identify functional genomic binding sites for sequence-specific transactivators.

Authors:  Jamie M Hearnes; Deborah J Mays; Kristy L Schavolt; Luojia Tang; Xin Jiang; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

2.  Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5.

Authors:  Margret Mandl; David N Slack; Stephen M Keyse
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  Chromosomal instability, tolerance of mitotic errors and multidrug resistance are promoted by tetraploidization in human cells.

Authors:  Anastasia Y Kuznetsova; Katarzyna Seget; Giuliana K Moeller; Mirjam S de Pagter; Jeroen A D M de Roos; Milena Dürrbaum; Christian Kuffer; Stefan Müller; Guido J R Zaman; Wigard P Kloosterman; Zuzana Storchová
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancer.

Authors:  Chao Cai; Jin-Yan Chen; Zhao-Dong Han; Hui-Chan He; Jia-Hong Chen; Yan-Ru Chen; Sheng-Bang Yang; Yong-Ding Wu; Yan-Ru Zeng; Jun Zou; Yu-Xiang Liang; Qi-Shan Dai; Fu-Neng Jiang; Wei-De Zhong
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  Knockout of Dual-Specificity Protein Phosphatase 5 Protects Against Hypertension-Induced Renal Injury.

Authors:  Chao Zhang; Xiaochen He; Sydney R Murphy; Huawei Zhang; Shaoxun Wang; Ying Ge; Wenjun Gao; Jan M Williams; Aron M Geurts; Richard J Roman; Fan Fan
Journal:  J Pharmacol Exp Ther       Date:  2019-05-22       Impact factor: 4.030

6.  An approach to genomewide screens of expressed small interfering RNAs in mammalian cells.

Authors:  Lianxing Zheng; Jun Liu; Sergei Batalov; Demin Zhou; Anthony Orth; Sheng Ding; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

Review 7.  p53 and E2f: partners in life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

8.  Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.

Authors:  Sivakumar Vijayaraghavalu; Josephine Kamtai Dermawan; Venugopalan Cheriyath; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2012-12-24       Impact factor: 4.939

9.  Regulation of p21 by TWIST2 contributes to its tumor-suppressor function in human acute myeloid leukemia.

Authors:  X Zhang; W Ma; J Cui; H Yao; H Zhou; Y Ge; L Xiao; X Hu; B-H Liu; J Yang; Y-Y Li; S Chen; C J Eaves; D Wu; Y Zhao
Journal:  Oncogene       Date:  2014-08-04       Impact factor: 9.867

10.  Withdrawal of BDNF from hippocampal cultures leads to changes in genes involved in synaptic function.

Authors:  Abigail Mariga; Jiri Zavadil; Stephen D Ginsberg; Moses V Chao
Journal:  Dev Neurobiol       Date:  2014-08-25       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.